The meta-analysis revealed that metformin administration demonstrated an association with significantly lower leptin concentrations after treatment than before treatment in the patients with PCOS, with a corresponding SMD of 0.65 (95% CI: 0.26 to1.04, P<0.05) (Fig 11). The gene discussed is LEP; the disease is polycystic ovary syndrome.